Antimyeloma activity of bromodomain inhibitors on the human myeloma cell line U266 by downregulation of MYCL.

Autor: Kazuhito Suzuki, Kouhei Yamamoto, Yasuhiro Arakawa, Hisashi Yamada, Keisuke Aiba, Masanobu Kitagawa
Zdroj: Anti-Cancer Drugs; Sep2016, Vol. 27 Issue 8, p756-765, 10p, 6 Graphs
Databáze: Complementary Index